Literature DB >> 6884414

Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon.

G A Lanfranchi, G Bazzocchi, L Marzio, M Campieri, C Brignola.   

Abstract

Sulpiride, a benzamide derivative, selectively antagonizes dopaminergic receptors within and outside the central nervous system. Dopamine has previously been shown to increase colonic motility. In the present investigation the motor response of the pelvic colon to a standard 1000 calorie meal was studied in 12 patients with the irritable bowel syndrome. The meal induced a significant increase in motor activity, lasting for 1 h and greatest in the first 30 min. In 6 cases the administration of sulpiride 100 mg i.m. significantly reduced the postprandial increase in colonic motor activity. Thus dopaminergic receptors may be involved in the colonic motor response to food.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884414     DOI: 10.1007/bf00607085

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Effects of glucagon and secretin on food- or morphine-induced motor activity of the distal colon, rectum, and anal sphincter.

Authors:  A R Chowdhury; S H Lorber
Journal:  Am J Dig Dis       Date:  1977-09

2.  [Sulpiride for peptic ulcer].

Authors:  A Cornet; M Grivaux
Journal:  Sem Hop       Date:  1969-03-14

3.  Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

Authors:  R F Harvey; A E Read
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

4.  The effect of sulpiride on gastric motility.

Authors:  J O Stadaas; S Aune
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

5.  [Chemical consitution and biological properties of sulpiride].

Authors:  L Justin-Besançon; M Thominet; C Laville; J Margarit
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1967-10-23

6.  Distal colon motility in schizophrenic patients.

Authors:  F Lechin; F Gômez; B van der Dijs; E Lechin
Journal:  J Clin Pharmacol       Date:  1980-07       Impact factor: 3.126

7.  Effect of dopamine on human gastric and pancreatic secretion.

Authors:  J E Valenzuela; C Defilippi; G Diaz; E Navia; Y Merino
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study.

Authors:  S K Lam; K C Lam; C L Lai; C K Yeung; L Y Yam; W S Wong
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

9.  Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors.

Authors:  G A Lanfranchi; L Marzio; C Cortini; E M Osset
Journal:  Am J Dig Dis       Date:  1978-03

10.  Stimulation of pancreatic secretion by sulpiride.

Authors:  L Gullo; V Nesticó; L Ferrini; C Daniele; P Priori; R Muratori; G Labó
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199

View more
  2 in total

1.  Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.

Authors:  G A Lanfranchi; G Bazzocchi; M Campieri; C Brignola; F Fois; B P Imbimbo
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.

Authors:  Dohoon Kim; Wooseong Kim; Seongkeun Jeong; Dayoon Kim; Jin-Wook Yoo; Yunjin Jung
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.